FBIA Comments on FDA Proposed Rule to Revoke Methods of Analysis Regulation
ASTA signed onto a coalition comment letter to the Food and Drug Administration(FDA) in September 2022 on the U.S. Food and Drug Administration (FDA or agency) proposed rule, Revocation of Methods of Analysis Regulation, revoking the methods of analysis regulation, § 2.19 (21 CFR 2.19), which describes an FDA policy to use certain methods of analysis to support FDA enforcement, as needed, and when the method of analysis is not prescribed in a regulation.
09/26/2022 at 5:15 am
0
Related Resources
FBIA Comments on FDA's Appendix 1
ASTA signed onto the FBIA coalition's comments to the Food and Drug Administration (FDA) in August 2024 on FDA's revisions to “Appendix 1: Potential Hazards for Foods and Processes” of the “Hazard Analysis and Risk-Based Preventive Controls for Human Food; Draft Guidance for Industry".
Hill Day 2009 ASTA Handout
This document is a handout that was distributed by ASTA on Hill Day in October 2009. It covers traceability, country of origin labeling, positive lab results to FDA, and administrative detention authority expansion.